Literature DB >> 11397665

The Type 1 growth factor receptors and their ligands considered as a complex system.

W J Gullick1.   

Abstract

The Type 1 family of growth factors and their receptors play an important role in normal development, wound healing and in diseases such as cancer. The products of the four receptor genes and the ten genes specifying ligands interact in a complex pattern. Such systems may develop emergent properties which cannot be predicted from a reductionist analysis of the interactions of individual components. New methods of determining these higher level properties are, however, being developed. These include microscopic analysis of live cells expressing fluorescently tagged ligands, receptors and second messengers which can provide positional information on components of the system. Computational simulations of the complex interactions are being developed which can help to predict the properties of the system.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11397665     DOI: 10.1677/erc.0.0080075

Source DB:  PubMed          Journal:  Endocr Relat Cancer        ISSN: 1351-0088            Impact factor:   5.678


  15 in total

Review 1.  The role of the epidermal growth factor receptor in breast cancer.

Authors:  Samuel K Chan; Mark E Hill; William J Gullick
Journal:  J Mammary Gland Biol Neoplasia       Date:  2006-01       Impact factor: 2.673

2.  Cellular uptake of radioiodine delivered by trastuzumab can be modified by the addition of epidermal growth factor.

Authors:  Erika Nordberg; Ann-Charlott Steffen; Mikael Persson; Asa L Sundberg; Jörgen Carlsson; Bengt Glimelius
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-03-12       Impact factor: 9.236

3.  In vitro combined treatment with cetuximab and trastuzumab inhibits growth of colon cancer cells.

Authors:  T Luca; V Barresi; G Privitera; N Musso; M Caruso; D F Condorelli; S Castorina
Journal:  Cell Prolif       Date:  2014-08-08       Impact factor: 6.831

4.  Nimbolide inhibits invasion and migration, and down-regulates uPAR chemokine gene expression, in two breast cancer cell lines.

Authors:  P Elumalai; A Brindha Mercy; R Arunkamar; G Sharmila; F A Bhat; S Balakrishnan; P Raja Singh; J Arunakaran
Journal:  Cell Prolif       Date:  2014-12       Impact factor: 6.831

5.  Phosphorylation of ErbB4 on tyrosine 1056 is critical for ErbB4 coupling to inhibition of colony formation by human mammary cell lines.

Authors:  Sarah E Pitfield; Ianthe Bryant; Desi J Penington; Gar Park; David J Riese
Journal:  Oncol Res       Date:  2006       Impact factor: 5.574

6.  Application of Multiplex Ligation-Dependent Probe Amplification in Determining the Copy Number Alterations of HER Gene Family Members in Invasive Ductal Breast Carcinoma.

Authors:  Mohsen Soosanabadi; Reza Mirfakhraie; Lilit Atanesyan; Akbar Biglarian; Fatemeh Aghakhani Moghadam; Maryam Rahimi; Farkhondeh Behjati; Elaheh Keyhani
Journal:  Rep Biochem Mol Biol       Date:  2019-04

7.  Insight into the recognition patterns of the ErbB receptor family transmembrane domains: heterodimerization models through molecular dynamics search.

Authors:  Oumarou Samna Soumana; Norbert Garnier; Monique Genest
Journal:  Eur Biophys J       Date:  2008-03-26       Impact factor: 2.095

8.  Immunohistochemical discrimination of wild-type EGFR from EGFRvIII in fixed tumour specimens using anti-EGFR mAbs ICR9 and ICR10.

Authors:  H Modjtahedi; S A Khelwatty; R S Kirk; A M Seddon; S Essapen; C A Del Vecchio; A J Wong; S Eccles
Journal:  Br J Cancer       Date:  2012-02-07       Impact factor: 7.640

Review 9.  Update on HER-2 as a target for cancer therapy: alternative strategies for targeting the epidermal growth factor system in cancer.

Authors:  W J Gullick
Journal:  Breast Cancer Res       Date:  2001-10-01       Impact factor: 6.466

Review 10.  A new model for ductal carcinoma in situ suggests strategies for treatment.

Authors:  William John Gullick
Journal:  Breast Cancer Res       Date:  2002-07-19       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.